Physician

Ardeshir Hashmi, M.D.

According to 2025 Medicare claims, Ardeshir Hashmi, M.D. (NPI: 1619143492) practices geriatric medicine in the Cleveland, OH market, with the plurality of this provider's patient population coming from Cuyahoga, OH. This provider's primary affiliated billing organization is THE CLEVELAND CLINIC FOUNDATION (NPI: 1679525919; TIN: 340714585) and primary practice location at 44195-0001. Hashmi is affiliated with the Cleveland Clinic Medicare ACO, LLC (ACO ID: A2729), participating under the MSSP model.

Hashmi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 323 traditional Medicare patients, billed 733 HCPCS/CPT codes, and received $41,656 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 3,553 prescription claims across 485 beneficiaries totaling $139,299 in drug costs, led by Myrbetriq (Mirabegron). 2023 DME data shows 24 claims. Open Payments data shows 2 records totaling $138. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $157,685 to $41,656. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $209,202 and ending at $139,299. In contrast, DME billing represents a smaller volume and moved from a higher plateau to a lower plateau, from $12,046 to $3,637.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	446	2,051	$157,685
2016	671	2,173	$161,116
2017	516	1,247	$92,995
2018	320	500	$30,693
2019	372	636	$40,040
2020	356	696	$47,277
2021	347	675	$47,429
2022	343	677	$46,682
2023	350	612	$45,004
2024	323	733	$41,656

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	298	3,180	$209,202
2016	449	4,226	$234,505
2017	428	3,975	$256,325
2018	437	1,613	$102,277
2019	393	2,528	$119,079
2020	413	3,227	$190,527
2021	427	3,434	$178,203
2022	468	3,456	$177,554
2023	488	3,394	$181,606
2024	485	3,553	$139,299

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	164	$7,235
2016	12	152	$6,182
2017	N/R	163	$6,323
2018	N/R	38	$1,669
2019	N/R	64	$1,303
2020	N/R	177	$6,453
2021	N/R	88	$1,921
2022	N/R	54	$1,810
2023	N/R	24	$2,162
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	29	29	$134
99483	Assessment of and care planning for patient with impaired thought processing, typically 60 minutes	74	74	$121
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	262	403	$61
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	166	187	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	48	1,817	$29,755
Memantine Hcl	Memantine Hcl	384	20,711	$12,910
Gemtesa	Vibegron	20	731	$11,538
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	21	630	$9,756
Eliquis	Apixaban	12	390	$7,655

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$138	UCB, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ardeshir Hashmi, M.D.?

Tedicare shows public-source Medicare data for Ardeshir Hashmi, M.D. (NPI 1619143492), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ardeshir Hashmi, M.D. have ACO affiliation data?

Ardeshir Hashmi, M.D. is shown with ACO affiliation data for Cleveland Clinic Medicare ACO, LLC (MSSP, ACO ID A2729).

What billing organization is linked to Ardeshir Hashmi, M.D.?

Ardeshir Hashmi, M.D. is linked to THE CLEVELAND CLINIC FOUNDATION (billing NPI 1679525919) in the available physician profile data.

Does Ardeshir Hashmi, M.D. have Open Payments data?

Ardeshir Hashmi, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.